Arkolith/Insider Trading/PDSB/Form 4

Hill Matthew C

Chief Financial OfficerPDS Biotechnology Corp (PDSB) · full profile →Form 4 · filed Dec 14, 2021
Net Buying
Open-Market Buys
$28K
Open-Market Sells
$0
Net Open-Market Flow
$28K
Transactions
4
4 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 13, 2021Buy(P)3K$9.00$23K3K
Dec 13, 2021Buy(P)400$8.90$4K4K
Dec 13, 2021Buy(P)100$9.00$9004K
Dec 13, 2021Buy(P)100$9.00$9004K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001140361-21-041473) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for PDS Biotechnology Corp

Build

Ask your agent about PDSB insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Get a key Compare plansForm 4 data
Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001140361-21-041473"
Ask your agent
Use Arkolith to summarize insider buying and selling at PDS Biotechnology Corp
over the last 90 days and cite the filings.